EUVIMEDEUVIMED entdecken
MetaanalyseSystematische ÜbersichtOpen Access · CC BY-NC 4.0

Coronary Revascularization for Heart Failure with Coronary Artery Disease: A Systematic Review and Meta-Analysis of Randomized Trials

Antonio Iaconelli, Pierpaolo Pellicori, Pasquale Dolce, Matteo Busti, Aureliano Ruggio, Nadia Aspromonte, Domenico D'Amario, Mattia Galli, Giuseppe Princi, Elisabetta Caiazzo, Asma O M Rezig, Pasquale Maffia und 3 weitere

European Journal of Heart Failure · 01.07.2023 · 25 (7) · 1094-1104

DOI: 10.1002/ejhf.2911 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift European Journal of Heart Failure, online erschienen am 29.06.2023. Verfasst von Antonio Iaconelli und 14 weiteren Autor:innen. Beteiligte Einrichtung: School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, UK. Hauptthemen laut MEDLINE: Coronary Artery Disease, Heart Failure, Percutaneous Coronary Intervention. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Coronary artery disease (CAD) is a common cause of heart failure (HF). Whether coronary revascularization improves outcomes in patients with HF receiving guideline-recommended pharmacological therapy (GRPT) remains uncertain; therefore, we conducted a systematic review and meta-analysis of relevant randomized controlled trials (RCTs). Methods and results We searched in public databases for RCTs published between 1 January 2001 and 22 November 2022, investigating the effects of coronary revascularization on morbidity and mortality in patients with chronic HF due to CAD. All-cause mortality was the primary outcome. We included five RCTs that enrolled, altogether, 2842 patients (most aged <65 years; 85% men; 67% with left ventricular ejection fraction ≤35%). Overall, compared to medical therapy alone, coronary revascularization was associated with a lower risk of all-cause mortality (hazard ratio [HR] 0.88, 95% confidence interval [CI] 0.79–0.99; p = 0.0278) and cardiovascular mortality (HR 0.80, 95% CI 0.70–0.93; p = 0.0024) but not the composite of hospitalization for HF or all-cause mortality (HR 0.87, 95% CI 0.74–1.01; p = 0.0728). There were insufficient data to show whether the effects of coronary artery bypass graft surgery or percutaneous coronary intervention were similar or differed.

Conclusions

For patients with chronic HF and CAD enrolled in RCTs, the effect of coronary revascularization on all-cause mortality was statistically significant but neither substantial (HR 0.88) nor robust (upper 95% CI close to 1.0). RCTs were not blinded, which may bias reporting of the cause-specific reasons for hospitalization and mortality. Further trials are required to determine which patients with HF and CAD obtain a substantial benefit from coronary revascularization by either coronary artery bypass graft surgery or percutaneous coronary intervention.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Coronary Artery DiseaseHeart FailurePercutaneous Coronary InterventionMaleHumansFemaleRandomized Controlled Trials as TopicCoronary Artery BypassStroke VolumeTreatment Outcome

Stichwörter der Autor:innen

Coronary artery diseaseHeart failureRevascularization

Autor:innen und Institutionen

  • School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, UK.
  • Department of Cardiovascular Medicine, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
  • Department of Public Health, University of Naples Federico II, Naples, Italy.
  • Department of Cardiovascular Sciences, Catholic University of the Sacred Heart, Rome, Italy.
  • Department of Translational Medicine, University of Eastern Piedmont, Novara, Italy.
  • Division of Cardiology, Azienda Ospedaliero Universitaria 'Maggiore della Carità', Novara, Italy.

Zitieren

APA

Iaconelli, A., Pellicori, P., Dolce, P., Busti, M., Ruggio, A., Aspromonte, N., D'Amario, D., Galli, M., Princi, G., Caiazzo, E., Rezig, A. O. M., Maffia, P., Pecorini, G., Crea, F., & Cleland, J. G. F. (2023). Coronary Revascularization for Heart Failure with Coronary Artery Disease: A Systematic Review and Meta-Analysis of Randomized Trials. European Journal of Heart Failure, 25(7), 1094-1104. https://doi.org/10.1002/ejhf.2911

Vancouver

Iaconelli A, Pellicori P, Dolce P, Busti M, Ruggio A, Aspromonte N, et al. Coronary Revascularization for Heart Failure with Coronary Artery Disease: A Systematic Review and Meta-Analysis of Randomized Trials. European Journal of Heart Failure. 2023;25(7):1094-1104. doi:10.1002/ejhf.2911

BibTeX
@article{Iaconelli2023,
  author = {Iaconelli, Antonio and Pellicori, Pierpaolo and Dolce, Pasquale and Busti, Matteo and Ruggio, Aureliano and Aspromonte, Nadia and D'Amario, Domenico and Galli, Mattia and Princi, Giuseppe and Caiazzo, Elisabetta and Rezig, Asma O M and Maffia, Pasquale and Pecorini, Giovanni and Crea, Filippo and Cleland, John G F},
  title = {Coronary Revascularization for Heart Failure with Coronary Artery Disease: A Systematic Review and Meta-Analysis of Randomized Trials},
  journal = {European Journal of Heart Failure},
  year = {2023},
  volume = {25},
  number = {7},
  pages = {1094--1104},
  doi = {10.1002/ejhf.2911}
}
Kostenlos starten →